• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝移植后非酒精性脂肪性肝病:先天与后天。

Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.

出版信息

Am J Gastroenterol. 2010 Mar;105(3):621-3. doi: 10.1038/ajg.2009.720.

DOI:10.1038/ajg.2009.720
PMID:20203643
Abstract

Non-alcoholic fatty liver disease (NAFLD) is a common cause of chronic liver disease. Most patients with cryptogenic cirrhosis are considered to have had "burned out NAFLD." Although the recurrence and progression of NAFLD after liver transplantation (LT) have been shown previously, the incidence of de novo NAFLD after LT has not been extensively reported. In this issue of the American Journal of Gastroenterology, Dumortier et al. report the incidence of de novo post-LT NAFLD. Although most of the risk factors for post-LT NAFLD are similar to those for primary NAFLD, hepatic steatosis in the donor livers and a pre-transplant diagnosis of alcoholic liver disease remain independent risk factors. Although there are some limitations, this study provides the largest cohort of patients for whom post-LT NAFLD is reported.

摘要

非酒精性脂肪性肝病(NAFLD)是慢性肝病的常见病因。大多数隐源性肝硬化患者被认为患有“枯竭性 NAFLD”。尽管先前已经证明了肝移植(LT)后 NAFLD 的复发和进展,但 LT 后新发 NAFLD 的发生率尚未得到广泛报道。在本期《美国胃肠病学杂志》中,Dumortier 等人报告了 LT 后新发 NAFLD 的发生率。尽管 LT 后 NAFLD 的大多数危险因素与原发性 NAFLD 相似,但供体肝脏中的肝脂肪变性和移植前酒精性肝病的诊断仍然是独立的危险因素。尽管存在一些局限性,但本研究提供了最大的 LT 后 NAFLD 患者队列。

相似文献

1
Non-alcoholic fatty liver disease after liver transplantation: a case of nurture and nature.肝移植后非酒精性脂肪性肝病:先天与后天。
Am J Gastroenterol. 2010 Mar;105(3):621-3. doi: 10.1038/ajg.2009.720.
2
Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".肝移植受者的非酒精性脂肪性肝病:“种子与土壤”的又一故事。
Am J Gastroenterol. 2010 Mar;105(3):613-20. doi: 10.1038/ajg.2009.717. Epub 2009 Dec 29.
3
Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.肝移植受者中经组织学证实的非酒精性脂肪性肝病及临床相关因素
Clin Transplant. 2014 May;28(5):521-9. doi: 10.1111/ctr.12343. Epub 2014 Apr 16.
4
De novo nonalcoholic fatty liver disease after liver transplantation.肝移植后新发非酒精性脂肪性肝病
Liver Transpl. 2007 Jun;13(6):844-7. doi: 10.1002/lt.20932.
5
Non-alcoholic steatohepatitis in children.儿童非酒精性脂肪性肝炎
Pediatr Transplant. 2004 Dec;8(6):613-8. doi: 10.1111/j.1399-3046.2004.00241.x.
6
Prevalence and clinical associations of posttransplant fatty liver disease.移植后脂肪肝疾病的患病率及临床关联
Liver Int. 2007 Feb;27(1):76-80. doi: 10.1111/j.1478-3231.2006.01396.x.
7
Recurrent or de novo nonalcoholic fatty liver disease after liver transplantation: natural history based on liver biopsy analysis.肝移植后复发性或新发非酒精性脂肪性肝病:基于肝活检分析的自然病史
Liver Transpl. 2014 Sep;20(9):1064-71. doi: 10.1002/lt.23936.
8
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?亚太地区非酒精性脂肪性肝病的风险因素及相关情况有哪些?
J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13.
9
[Non-alcoholic fatty liver disease--new view].[非酒精性脂肪性肝病——新视角]
Pol Merkur Lekarski. 2008 Jun;24(144):568-71.
10
Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.饮酒与非酒精性脂肪性肝病的肝纤维化进展相关。
Scand J Gastroenterol. 2009;44(3):366-74. doi: 10.1080/00365520802555991.

引用本文的文献

1
Liver Transplantation (LT) for Cryptogenic Cirrhosis (CC) and Nonalcoholic Steatohepatitis (NASH) Cirrhosis: Data from the Scientific Registry of Transplant Recipients (SRTR): 1994 to 2016.隐源性肝硬化(CC)和非酒精性脂肪性肝炎(NASH)肝硬化的肝移植(LT):来自移植受者科学登记处(SRTR)的数据:1994年至2016年。
Medicine (Baltimore). 2018 Aug;97(31):e11518. doi: 10.1097/MD.0000000000011518.
2
Long-term administration of tacrolimus and everolimus prevents high cholesterol-high fructose-induced steatosis in C57BL/6J mice by inhibiting de-novo lipogenesis.长期给予他克莫司和依维莫司可通过抑制从头脂肪生成,预防高胆固醇-高果糖诱导的C57BL/6J小鼠脂肪变性。
Oncotarget. 2017 Feb 8;8(69):113403-113417. doi: 10.18632/oncotarget.15194. eCollection 2017 Dec 26.
3
Quality of life 10 years after liver transplantation: The impact of graft histology.肝移植术后10年的生活质量:移植肝组织学的影响。
World J Transplant. 2016 Dec 24;6(4):703-711. doi: 10.5500/wjt.v6.i4.703.
4
Ethanol and liver: recent insights into the mechanisms of ethanol-induced fatty liver.乙醇与肝脏:乙醇诱导脂肪肝机制的最新见解
World J Gastroenterol. 2014 Oct 28;20(40):14672-85. doi: 10.3748/wjg.v20.i40.14672.
5
MR spectroscopy as a tool for in vivo determination of steatosis in liver transplant recipients.磁共振波谱分析作为一种活体检测肝移植受者脂肪变性的工具。
MAGMA. 2011 Oct;24(5):297-304. doi: 10.1007/s10334-011-0264-9. Epub 2011 Jul 10.